A few days ago, the World Health Organization announced the emergency approval of the Moderna vaccine that paves the way for its inclusion in the UN-backed COVAX program.
Vaccine distribution is not equitable
Gavi, a Geneva-based public-private partnership, has sought agreements with vaccine manufacturers while trying to convince rich countries that have secured millions of doses – some of which they do not use – to donate some to the poorest countries.
On the other hand, the alliance announced that the Swedish government has committed to donate 1 million doses of the Oxford-AstraZeneca vaccine “to help COVAX to urgently solve the delays in the provision of immediate term”.
Moderna is already supplying many rich countries with millions of doses of its vaccine. The who has repeatedly denounced the lack of equity in access to vaccines against COVID-19.
A large vaccine production on the way
Moderna’s vaccine production is scheduled to begin in the fourth quarter of the year, and the vast majority of the deal’s doses – 466 million – will take place next year. For this year 34 million doses are planned.
Stephane Bancel, CEO of Moderna, expressed his support for the COVAX mission and said that the agreement is “an important milestone” to ensure global access to its vaccine.
The post Moderna will provide 500 million doses of vaccine to WHO appeared first on Hispanic World.